Browse MakeaGif's great section of animated GIFs, or make your very own. Upload, customize and create the best GIFs with our free GIF animator! See it. GIF it. Share it.

PROTACs are small molecules that can be tailored to tag particular proteins. The PROTAC also binds to a naturally-occurring protein that ultimately results in the disease protein being degraded by the body’s natural disposal system.

https://xvivo.com/examples/protac-platform-animation/The biopharmaceutical company Arvinas Inc. has taken a unique approach to develop investigational therap...

Based on proteolysis-targeting chimera (PROTAC) technology, a small set of novel GSK-3β degraders was designed and synthesized by linking two different GSK-3β inhibitors, SB-216763 and ...

A proteolysis targeting chimera (PROTAC) [2] is a molecule that can remove specific unwanted proteins. Rather than acting as a conventional enzyme inhibitor , a PROTAC works by inducing selective intracellular proteolysis .

Nov 1, 2022 · PROTACs provide a new mechanism in that they dramatically reduce the cellular availability of a protein of interest (POI) with high selectivity yet greatly reduced side effects in comparison to traditional small molecule inhibitors [1].

In this review, we describe recent PROTAC developments, focusing on mechanistic and kinetic studies, pharmacokinetic study, spatiotemporal control of PROTACs, covalent PROTACs, resistance to PROTACs, and new E3 ligands.

Targeted protein degradation by Proteolysis-Targeting Chimeras (PROTACs) for undruggable drug targets. Proteolysis Targeting Chimeras (PROTACs) represent a paradigm shift in drug discovery and therapeutic intervention, offering a powerful approach to address previously “undruggable” targets.

MZ1 is a first in class PROTAC (proteolysis-targeting chimeras) that tethers JQ1 to a VHL E3 ubiquitin ligase ligand, aimed at triggering the intracellular destruction of BET proteins. It induces reversible, long-lasting, and preferential removal of BRD4 over BRD2 and BRD3 in cells.

Jan 1, 2025 · Proteolysis Targeting Chimeras (PROTACs) are novel molecules which used to degrade particular proteins despite the blockage by small drug molecules, which leads to a predicted therapeutic activity. This is a unique finding, …